Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase

Adenosine 5'-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype

(2014) D. Sag et al.   JOURNAL OF IMMUNOLOGY

Retinoblastoma Regression Patterns Following Chemoreduction and Adjuvant Therapy in 557 Tumors

(2009) Carol L. Shields   ARCHIVES OF OPHTHALMOLOGY

p21WAF1/CIP1and cancer: A shifting paradigm?

(2009) Andrei L. Gartel   BIOFACTORS

AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D

(2009) Yi Zang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemoreduction for Group E Retinoblastoma: Comparison of Chemoreduction Alone Versus Chemoreduction Plus Low-Dose External Radiotherapy in 76 Eyes

(2009) Carol L. Shields et al.   OPHTHALMOLOGY

Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death

(2009) Guillaume Robert et al.   PLoS One

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis

(2009) D. Guo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Survival with retinoblastoma in the USA: 1975-2004

(2008) E Broaddus et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

AMPK and PPARδ Agonists Are Exercise Mimetics

(2008) Vihang A. Narkar et al.   CELL

Forget-Me-Nots in the Care of Children with Retinoblastoma

(2008) Carol L. Shields   Seminars in Ophthalmology